Cite Score:
0.89
CITE SCORE SCOPUS

Loss of P16 Protein Expression and Its Association with Epstein‐Barr Virus LMP‐1 Expression in Hodgkin's Lymphoma

AUTHORS

Fawzi Irshaid 1 , * , Khaled Tarawneh 2 , Aisha Alshdefat 3 , Fatiha Dilmi 1 , Adnan Jaran 1 , Raji Al‐Hadithi 4 , Ahad Al‐Khatib 4

1 Dept. of Biological Sciences, Faculty of Science, Al al-Bayt University, Al-Mafraq, Jordan

2 Dept. of Biological Sciences, Faculty of Science, Mutah University, Mutah, Jordan

3 Mafraq Hospital of Children and Maternity, Al-Mafraq, Jordan

4 Dept. of Pathology, Faculty of Medicine, Jordan University of Sciences and Technology, Irbid, Jordan

How to Cite: Irshaid F , Tarawneh K, Alshdefat A, Dilmi F, Jaran A, et al. Loss of P16 Protein Expression and Its Association with Epstein‐Barr Virus LMP‐1 Expression in Hodgkin's Lymphoma, Int J Cancer Manag. 2013 ; 6(2):e80404.

ARTICLE INFORMATION

International Journal of Cancer Management: 6 (2); e80404
Published Online: June 30, 2013
Article Type: Research Article
Received: January 29, 2013
Accepted: February 23, 2013

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Expression of Epstein-Barr virus Latent Member Protein-1 (EBV LMP1) and loss of P16 protein expression are documented in lymphoma, indicating a relationship between them, but this relationship is not clear and sometimes contradictory. Thus, this study was conducted to examine the relationship between the loss of P16 and EBV LMP-1 expression in Jordanian patients diagnosed with lymphoma.

Methods: Sections were made from archival formalin-fixed and paraffinembedded blocks from 55 patients diagnosed with lymphoma. P16 expression and LMP-1 expression were detected by immunohistochemistry using monoclonal antibodies.

Results: In Hodgkin's Lymphoma (HL), the loss of P16 was higher in LMP-1 positive cases (61%) than LMP-1 negative cases (25%; P = 0.072). Conversely, in NonHodgkin's Lymphoma (NHL), none of LMP-1 positive samples showed loss of P16. Furthermore, among LMP-1 HL positive cases, the loss of P16 was more frequent in male (75%) than female (33%). Also, there was a significantly higher proportion of LMP-1 positive cases showing loss of P16 in HL (11:18), compared to those in NHL (0:8, P < 0.001), confirming a difference between HL and NHL, concerning the LMP-1/P16 relationship.

Conclusion: A trend for an association between loss of P16 and LMP-1 expression was observed in HL but not NHL patients. These findings suggest that there are molecular and clinical differences in the pathogenesis and development of different subtypes of lymphoma.

Keywords

Epstein-Barr virus infections Immunohistochemistry Lymphoma Monoclonal antibodies

© 2013, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

The Full text is available in PDF.

COMMENTS

LEAVE A COMMENT HERE: